| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 20% | +37% | $19,659,686 | +$13,749,450 | 11,914,961 | +233% | BEHZAD AGHAZADEH | 28 Feb 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 10% | $7,800,392 | 4,727,510 | SUVRETTA CAPITAL MANAGEMENT, LLC | 04 Mar 2025 | |||
| ORBIMED ADVISORS LLC | 8.9% | $6,873,900 | 4,166,000 | OrbiMed Advisors LLC | 31 Mar 2025 | |||
| ABG Management Ltd. | 6.3% | $4,809,098 | 2,914,605 | Fan Yu | 04 Mar 2025 | |||
| Coastlands Capital LP | 6% | $4,820,858 | 2,819,215 | Coastlands Capital LP | 19 Aug 2025 | |||
| BML Investment Partners, L.P. | 5% | -49% | $4,017,750 | -$255,149 | 2,435,000 | 0% | Leonard Braden Michael | 05 Mar 2025 |
| QVT Financial LP | 9.4% | $3,817,608 | 2,313,702 | QVT Financial LP | 31 Dec 2024 | |||
| Desai Neil | 4.9% | -48% | $3,750,353 | +$15,469 | 2,272,941 | +0.41% | Neil Desai | 04 Mar 2025 |
| ACUTA CAPITAL PARTNERS, LLC | 7.8% | $3,170,140 | 1,921,297 | Anupam Dalal | 19 Dec 2024 | |||
| EcoR1 Capital, LLC | 1.4% | $569,667 | 345,253 | EcoR1 Capital, LLC | 31 Dec 2024 | |||
| Point72 Asset Management, L.P. | 0% | -100% | $8,394 | -$2,417,620 | 5,087 | -100% | Point72 Asset Management, L.P. | 31 Mar 2025 |
| Satter Muneer A | 0% | $1,087 | 659 | Satter Muneer A | 31 Dec 2024 |
As of 30 Sep 2025, 39 institutional investors reported holding 28,831,370 shares of Whitehawk Therapeutics, Inc. - Common stock (WHWK). This represents 61% of the company’s total 47,144,064 outstanding shares.
The largest institutional shareholders of Whitehawk Therapeutics, Inc. - Common stock (WHWK) together control 61% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| QVT Financial LP | 9.8% | 4,615,709 | 0% | 0.92% | $8,331,355 |
| ORBIMED ADVISORS LLC | 8.8% | 4,166,000 | 0% | 0.19% | $7,915,400 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7.8% | 3,700,000 | 0% | 0.21% | $7,030,000 |
| ACUTA CAPITAL PARTNERS, LLC | 7.2% | 3,410,402 | 0% | 6.7% | $6,479,764 |
| Avoro Capital Advisors LLC | 6% | 2,849,402 | 0% | 0.07% | $5,413,864 |
| Siren, L.L.C. | 4.4% | 2,082,000 | 0% | 0.15% | $3,955,800 |
| Yu Fan | 4.4% | 2,070,000 | 0% | 5.1% | $3,933,000 |
| VANGUARD GROUP INC | 2.8% | 1,342,907 | +2.1% | 0% | $2,551,523 |
| ACORN CAPITAL ADVISORS, LLC | 2.4% | 1,139,363 | 0% | 1.1% | $2,164,790 |
| Ally Bridge Group (NY) LLC | 1.7% | 817,939 | 0% | 1.3% | $1,554,084 |
| RENAISSANCE TECHNOLOGIES LLC | 0.97% | 457,422 | -0.17% | 0% | $869,102 |
| STEMPOINT CAPITAL LP | 0.9% | 424,082 | 0.16% | $805,756 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.81% | 381,754 | +2.5% | 0% | $725,695 |
| Peapod Lane Capital LLC | 0.64% | 303,585 | +25% | 0.52% | $577,064 |
| BlackRock, Inc. | 0.63% | 296,158 | -0.72% | 0% | $562,701 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.46% | 215,284 | -32% | 0.01% | $409,040 |
| CITADEL ADVISORS LLC | 0.3% | 140,220 | +391% | 0% | $266,418 |
| Squarepoint Ops LLC | 0.18% | 83,660 | +36% | 0% | $158,954 |
| NORTHERN TRUST CORP | 0.15% | 72,164 | -22% | 0% | $137,111 |
| STATE STREET CORP | 0.15% | 68,737 | 0% | 0% | $130,600 |
| DIMENSIONAL FUND ADVISORS LP | 0.09% | 44,115 | -38% | 0% | $83,818 |
| Stonepine Capital Management, LLC | 0.07% | 35,253 | 0.05% | $66,981 | |
| ABG Innovation Capital Partners III GP Ltd | 0.06% | 26,666 | 0% | 100% | $50,665 |
| ACADIAN ASSET MANAGEMENT LLC | 0.06% | 26,206 | 0% | $49,000 | |
| JANE STREET GROUP, LLC | 0.05% | 25,215 | -76% | 0% | $47,908 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,333 | $3,226 | $2.42 | 1 | |
| 2025 Q3 | 28,831,370 | $54,340,996 | -$1,110,999 | $1.90 | 39 |
| 2025 Q2 | 29,433,136 | $54,608,497 | -$892,348 | $1.87 | 38 |
| 2025 Q1 | 31,810,129 | $56,220,211 | +$29,068,779 | $1.78 | 48 |
| 2024 Q4 | 14,961,549 | $47,203,527 | +$5,014,221 | $3.16 | 51 |
| 2024 Q3 | 11,974,976 | $24,667,146 | +$1,827,649 | $2.06 | 51 |
| 2024 Q2 | 11,470,696 | $16,745,938 | -$3,331,884 | $1.46 | 62 |
| 2024 Q1 | 13,209,848 | $30,910,846 | +$1,317,345 | $2.34 | 59 |
| 2023 Q4 | 12,771,454 | $25,798,328 | -$10,724,875 | $2.02 | 61 |
| 2023 Q3 | 14,215,510 | $68,806,910 | +$1,723,608 | $4.84 | 68 |
| 2023 Q2 | 13,767,644 | $94,167,741 | -$902,416 | $6.84 | 64 |
| 2023 Q1 | 13,831,279 | $100,129,256 | -$16,765,643 | $7.24 | 68 |
| 2022 Q4 | 15,301,334 | $192,201,984 | +$3,020,207 | $12.83 | 74 |
| 2022 Q3 | 14,991,886 | $211,814,933 | +$32,835,650 | $14.13 | 65 |
| 2022 Q2 | 12,821,892 | $157,983,315 | +$4,293,670 | $12.32 | 64 |
| 2022 Q1 | 12,538,457 | $212,794,829 | -$7,695,432 | $16.97 | 50 |
| 2021 Q4 | 12,180,657 | $294,157,682 | +$23,865,901 | $24.15 | 42 |
| 2021 Q3 | 11,096,617 | $324,112,000 | +$324,112,035 | $29.37 | 30 |